We are live on
!
Find out more
KA
Kintegral Advisory Portfolio holdings
AUM
$1.23B
1-Year Est. Return
40.07%
This Fund
S&P 500
This Quarter
Est. Return
+9.68%
1 Year Est. Return
+40.07%
3 Year Est. Return
+123.97%
5 Year Est. Return
+164.78%
10 Year Est. Return
–
AUM
$846M
AUM Growth
+$67.3M
(+8.6%)
Cap. Flow
-$4.21M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
268
New
3
Increased
–
Reduced
2
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$519K |
| 2 |
American International
AIG
|
+$503K |
| 3 |
Organon & Co
OGN
|
+$340K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$3.72M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$552K |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$470K |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$463K |
| 5 |
Merck
MRK
|
+$368K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.14% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.48% |
| 4 | Communication Services | 12.39% |
| 5 | Consumer Discretionary | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Lowe's Companies
LOW
$115B
| $4.23M | 0.5% |
21,796
| – | – |
|
52
Bristol-Myers Squibb
BMY
$136B
| $4.21M | 0.5% |
63,061
| – | – |
|
53
UnitedHealth
UNH
$356B
| $4.19M | 0.5% |
10,466
| – | – |
|
54
CBRE Group
CBRE
$42.8B
| $4.18M | 0.49% |
48,754
| – | – |
|
55
Home Depot
HD
$320B
| $4.1M | 0.49% |
12,870
| – | – |
|
56
Starbucks
SBUX
$119B
| $4.05M | 0.48% |
36,234
| – | – |
|
57
IBM
IBM
$221B
| $3.98M | 0.47% |
28,408
| – | – |
|
58
PayPal
PYPL
$47B
| $3.94M | 0.47% |
13,516
| – | – |
|
59
Waters Corp
WAT
$40.2B
| $3.86M | 0.46% |
11,171
| – | – |
|
60
Mettler-Toledo International
MTD
$27B
| $3.85M | 0.45% |
2,777
| – | – |
|
61
Mastercard
MA
$507B
| $3.78M | 0.45% |
10,343
| – | – |
|
62
Equinix
EQIX
$102B
| $3.56M | 0.42% |
4,441
| – | – |
|
63
PNC Financial Services
PNC
$98B
| $3.15M | 0.37% |
16,487
| – | – |
|
64
Gilead Sciences
GILD
$187B
| $3.1M | 0.37% |
44,940
| – | – |
|
|
K
65
DELISTED
Kellanova
K
| $3.05M | 0.36% |
50,548
| – | – |
|
66
Booking.com
BKNG
$145B
| $3.04M | 0.36% |
34,675
| – | – |
|
67
Sempra
SRE
$55B
| $3.01M | 0.36% |
45,452
| – | – |
|
68
HP
HPQ
$29.4B
| $2.98M | 0.35% |
97,946
| – | – |
|
69
Deere & Co
DE
$187B
| $2.95M | 0.35% |
8,337
| – | – |
|
70
Idexx Laboratories
IDXX
$42.2B
| $2.93M | 0.35% |
4,643
| – | – |
|
|
SCHW
71
Charles Schwab
SCHW
$189B
| $2.93M | 0.35% |
40,195
| – | – |
|
72
Vertex Pharmaceuticals
VRTX
$138B
| $2.83M | 0.33% |
14,025
| – | – |
|
73
Clorox
CLX
$11.3B
| $2.82M | 0.33% |
15,672
| – | – |
|
74
General Mills
GIS
$20.5B
| $2.82M | 0.33% |
46,223
| – | – |
|
75
Henry Schein
HSIC
$10B
| $2.81M | 0.33% |
37,815
| – | – |
|
Similar funds
SPC
RIM
OA
CA
CT
SCP
RPC
CCFCSB
Kintegral Advisory's Q2 2021 Portfolio in Review
As of Q2 2021, Kintegral Advisory held 268 positions worth $846M, up 8.6% from $779M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 2.2%. Kintegral Advisory opened 3 new positions and exited 3, leaving the 268-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- Kintegral Advisory's largest Q2 2021 buy was Warner Bros: 14,974 shares worth $434K.
- Kintegral Advisory's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $3.72M.
- Kintegral Advisory fully exited Discovery, Inc. Series C Common Stock in Q2 2021, selling an estimated $552K.
- Kintegral Advisory's ten largest holdings make up 34% of its $846M portfolio in Q2 2021.
- Kintegral Advisory opened 3 new positions and closed 3 in Q2 2021.
- Kintegral Advisory's portfolio value rose 8.6% quarter-over-quarter to $846M.
Based on Kintegral Advisory's 13F filing for Q2 2021, filed 16 Aug 2021.